Tirzepatide’s dual receptor approach signals a new era in metabolic treatment, but safety and regulation are crucial

The emerging drug Tirzepatide, with its dual hormone receptor action, offers promising advances in weight and glucose management, yet concerns around digestive side effects and unregulated online marketing highlight the need for cautious oversight. Tirzepatide has become one of the…















